Article
Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
Pharmacogenetics and genomics - 1 Apr 2005
Miltiadous George, Xenophontos Stavroulla, Bairaktari Eleni, Ganotakis Manolis, Cariolou Marios, Elisaf Moses
Abstract excerpt
Familial hypercholesterolaemia (FH) is the most common inherited metabolic disease characterized by elevated serum levels of low-density lipoprotein cholesterol (LDL-C) and ischaemic heart disease early in life. Early diagnosis and treatment are essential to prevent premature atherosclerosis in FH patients. The aim of our study was the evaluation of the effects of genetic [class of the LDL receptor (LDLR) gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
